Series A/B warrants vesting at $2.25B/$2.5B EV
Company: Core Scientific
The claim, verbatim
Shareholders would receive two warrant series, each for up to 10% of new common interests and exercisable for seven years. Series A vests at an enterprise value of at least $2.25 billion and Series B at at least $2.5 billion.
Source (primary)
core-scientific 8-K exhibit (d509828dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-20)Live source ↗
Quote: “Series A: warrants to purchase up to ten percent (10%) of the New Common Interests on a fully diluted basis which will vest upon the total enterprise value of the Reorganized Debtors being at least $2,250,000,000”
How we checked this
Checked on November 21, 2026. The cited source supports every part of this claim.
A footnote to the document describes both warrant series, their 10% size, their seven-year exercise period, and the $2.25 billion and $2.5 billion vesting thresholds.
Confirmed in the source:
- Shareholders would receive two series of New Warrants
- Each series covers up to 10% of New Common Interests on a fully diluted basis
- Each series is exercisable for seven years
- Series A vests at a total enterprise value of at least $2.25 billion
- Series B vests at a total enterprise value of at least $2.5 billion
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523231176/d509828dex992.htm) in full (450,114 characters, retrieved November 20, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d509828dex992.htm)
Quote: “Series A: warrants to purchase up to ten percent (10%) of the New Common Interests on a fully diluted basis which will vest upon the total enterprise value of the Reorganized Debtors being at least $2,250,000,000”